Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US Report Summary GBI Research, the leading business intelligence provider, has released its latest report, “Emerging Market for Clinical Trials – Poland –” which provides key data, information and analysis of the major trends and issues affecting the clinical trial market in Poland. The report provides a comprehensive insight of the reasons for outsourcing clinical trials to Poland and the key services provided by the Clinical Research Organizations (CROs) of Poland. The report provides a detailed analysis of the Polish market in terms of its size, and major service offerings of the CROs in Poland. The report also discusses the factors that are driving the clinical trial market in Poland. The report delves into the key documents required by the investigator and the sponsor before, during and after the conduct of clinical trials. The report also provides key alliances in the CRO market. Furthermore, the report looks into the major challenges that can restrict the growth of the clinical trials market in Poland. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/130481-emerging-market-for-clinical-trials-inpoland-cost-advantages-of-nearly-30-as-compared-to-the-us.html Scope
The report analyses the clinical trial market in Poland, along with the major forces driving the current market and the potential challenges that could restrain the growth. The scope of the report includes: The need for outsourcing clinical trials to Poland. Trends in clinical trial registration in Poland and a comparative analysis of clinical trial registration in Eastern European countries. Analysis of the key drivers that are fueling the growth of the clinical trial market in Poland. Analysis of the key infrastructural facilities, clinical research professionals and principal investigators in Poland. Analysis of key government regulations in Poland affecting the clinical trial market. Study of 12 major CROs operating in Poland with SWOT analysis of large multinational CROs.
Reasons to Buy
The report will enhance your decision making capability in a rapid and time-sensitive manner. It will allow you to: Compare the key capabilities of major clinical trial service providers with your requirements and optimize your R&D costs.
Develop market entry and market expansion strategies by identifying the key drivers and challenges in the Polish clinical trials market. Develop effective strategies to maximize the advantages in Poland through understanding of the regulatory environment. Understand the regulatory structure in Poland and key documents required to register clinical trials in Poland.
Report Details: Published: December 2011 No. of Pages: 150 Price: Single User License – US$3500
Corporate User License – US$10500
Contact: Priyank Tiwari 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-391-5441 email@example.com Visit our Market Research Blog @ http://www.reportsnreportsblog.com/ Connect With Us:
Published on Dec 19, 2011
GBI Research’s “Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US” is now available at Rep...